Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elinzanetant for sleep disturbances in menopause
NCT06112756Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of elinzanetant, sponsored by Bayer. Started Nov 2023; status: completed.
02
Drugs
elinzanetant
Beyond the preview
Go deeper on NCT06112756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06112756.